These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 17194664

  • 1. Favourable outcome in an APL patient with PLZF/RARalpha fusion gene: quantitative real-time RT-PCR confirms molecular response.
    Cassinat B, Guillemot I, Moluçon-Chabrot C, Zassadowski F, Fenaux P, Tournilhac O, Chomienne C.
    Haematologica; 2006 Dec; 91(12 Suppl):ECR58. PubMed ID: 17194664
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cryptic insertion (15;17) in a case of acute promyelocytic leukemia detected by fluorescence in situ hybridization.
    Gutiérrez NC, García JL, Chillón C, Muntión S, González M, Hernández JM.
    Haematologica; 1999 Jan; 84(1):88-90. PubMed ID: 10091399
    [No Abstract] [Full Text] [Related]

  • 5. Diagnosis, front line treatment and molecular monitoring of acute promyelocytic leukaemia.
    Lo Coco F, Diverio D, Avvisati G, Mandelli F.
    Haematologica; 1999 Jun; 84 Suppl EHA-4():72-4. PubMed ID: 10907474
    [No Abstract] [Full Text] [Related]

  • 6. The PML/RAR alpha fusion gene in the diagnosis and monitoring of acute promyelocytic leukemia.
    Diverio D, Riccioni R, Mandelli F, Lo Coco F.
    Haematologica; 1995 Jun; 80(2):155-60. PubMed ID: 7628753
    [Abstract] [Full Text] [Related]

  • 7. A t(17;20)(q21;q12) masking a variant t(15;17)(q22;q21) in a patient with acute promyelocytic leukemia.
    García-Casado Z, Cervera J, Valencia A, Pajuelo JC, Mena-Duran AV, Barragán E, Bolufer P, Sanz MA.
    Cancer Genet Cytogenet; 2006 Jul 01; 168(1):73-6. PubMed ID: 16772124
    [Abstract] [Full Text] [Related]

  • 8. Long-term disease-free acute promyelocytic leukemia patients really can be cured at molecular level.
    Martinelli G, Ottaviani E, Visani G, Testoni N, Montefusco V, Tura S.
    Haematologica; 1998 Sep 01; 83(9):860-3. PubMed ID: 9825588
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Acute promyelocytic leukemia. New methods in diagnosis and treatment.
    Varghese L, Janckila A, Yam LT.
    J Ky Med Assoc; 1999 Feb 01; 97(2):61-5. PubMed ID: 10073058
    [Abstract] [Full Text] [Related]

  • 12. Long-term molecular remission in promyelocytic transformation of myeloproliferative disease.
    Mollee PN, Taylor KM, Williams B, Taylor D, Rodwell R.
    Leukemia; 1999 Apr 01; 13(4):648-50. PubMed ID: 10214878
    [No Abstract] [Full Text] [Related]

  • 13. Clinico-biological features and outcome of acute promyelocytic leukemia patients with persistent polymerase chain reaction-detectable disease after the AIDA front-line induction and consolidation therapy.
    Breccia M, Diverio D, Noguera NI, Visani G, Santoro A, Locatelli F, Damiani D, Marmont F, Vignetti M, Petti MC, Lo Coco F.
    Haematologica; 2004 Jan 01; 89(1):29-33. PubMed ID: 14754603
    [Abstract] [Full Text] [Related]

  • 14. A new variant t(6;15;17)(q25;q22;q21) in acute promyelocytic leukemia: fluorescence in situ hybridization confirmation.
    Eclache V, Viguie F, Frocrain C, Cassinat B, Chomienne C, Cymbalista F, Fenaux P.
    Cancer Genet Cytogenet; 2005 May 01; 159(1):69-73. PubMed ID: 15860361
    [Abstract] [Full Text] [Related]

  • 15. Acquired acute myelogenous leukemia after therapy for acute promyelocytic leukemia with t(15;17): a case report and review of the literature.
    Betancourt-García RD, Castro J, Fernández AC, López-Enríquez A, Fradera J, Pacheco E.
    P R Health Sci J; 2009 Jun 01; 28(2):146-50. PubMed ID: 19530558
    [Abstract] [Full Text] [Related]

  • 16. Microgranular and t(11;17)/PLZF-RARalpha variants of acute promyelocytic leukemia also present the flow cytometric pattern of CD13, CD34, and CD15 expression characteristic of PML-RARalpha gene rearrangement.
    Rizzatti EG, Portieres FL, Martins SL, Rego EM, Zago MA, Falcão RP.
    Am J Hematol; 2004 May 01; 76(1):44-51. PubMed ID: 15114596
    [Abstract] [Full Text] [Related]

  • 17. [Characterization of the universal Russian reagent sets for real-time PCR and its application for molecular oncodiagnostic].
    Manzeniuk OIu, Malakho SG, Pekhov VM, Kosorukova IS, Poltaraus AB.
    Mol Biol (Mosk); 2006 May 01; 40(2):349-56. PubMed ID: 16637276
    [Abstract] [Full Text] [Related]

  • 18. [Cytogenetic and molecular genetic studies on a variant of t(15;17), ins(17;15)(q21;q14q22), in an acute promyelocytic leukemia patient].
    Chen SN, Xue YQ, Wu YF, Pan JL.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb 01; 21(1):77-9. PubMed ID: 14767917
    [Abstract] [Full Text] [Related]

  • 19. [Detection of t(15;17) using cytogenetic, fluorescent in situ hybridization, and molecular techniques. Comparative study of 11 patients with acute promyelocytic leukemia].
    Arranz E, Robledo M, Martínez B, Prieto E, Román A, Benítez J.
    Sangre (Barc); 1997 Feb 01; 42(1):11-5. PubMed ID: 9229797
    [Abstract] [Full Text] [Related]

  • 20. Acute promyelocytic leukemia with del(6)(p23).
    Nakase K, Wakita Y, Minamikawa K, Yamaguchi T, Shiku H.
    Leuk Res; 2000 Jan 01; 24(1):79-81. PubMed ID: 10634650
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.